查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585666

生物製程验证市场：按测试类型、製程组件和最终用户划分 - 2025-2030 年全球预测

Bioprocess Validation Market by Test Type, Process Component, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物製程验证市场价值为3.9547亿美元，预计到2024年将达到4.5357亿美元，复合年增长率为14.78%，到2030年将达到10.3834亿美元。

生物工艺验证是生物技术和製药行业的关键组成部分，确保生技药品生产中涉及的工艺始终有效，并始终生产出符合指定规格和品质属性的产品。 FDA 和 EMA 等机构提出的严格监管要求产生了对生物製程验证的需求，需要严格的製程一致性和产品安全性证据。生物製程验证的主要发展涵盖药物开发和製造的各个阶段，从种植和收穫到精製和配方，并针对生物製药公司、契约製造组织 (CMO) 和研发机构等关键最终用户。市场成长受到生技药品和生物相似药需求增加、生物製药研发投资以及对个人化医疗日益关注的显着影响。此外，製程分析技术 (PAT) 和自动化的技术进步为提高生物製程效率和确保合规性提供了巨大的潜在机会。公司可以透过投资用于即时监控和控制生物过程的创新解决方案以及整合人工智慧和机器学习来进行预测分析和品管系统来利用这些机会。然而，市场面临着许多挑战，包括高昂的初始成本、复杂的製程设计以及抑制创新并减慢上市时间的法律规范。应对这些挑战需要提高具有成本效益的验证技术并开发强大的标准化通讯协定。最佳创新领域包括探索连续製造方法、引入用于预测生物加工的先进资料分析以及改进一次性技术以提高灵活性并减少交叉污染风险。这个市场的特点是动态性和技术快速发展，需要不断调整和前瞻性策略，才能成功驾驭竞争格局并推动永续成长。

主要市场统计
基准年[2023] 3.9547 亿美元
预测年份 [2024] 45357万美元
预测年份 [2030] 1,038,340,000 美元
复合年增长率（%） 14.78%

市场动态：快速发展的生物製程验证市场的关键市场洞察

供需的动态交互作用正在改变生物製程验证市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 精确的安全和品质法规
    • 生物製药需求不断成长
    • 生物製程验证外包需求不断成长
  • 市场限制因素
    • 生物製程验证高成本
  • 市场机会
    • 开发下一代生物产品的新验证方法
    • 细胞和基因疗法在医疗保健领域的兴起
  • 市场挑战
    • 验证过程中的功能问题

波特五力：驾驭生物製程验证市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物製程验证市场的外部影响

外部宏观环境因素在塑造生物过程验证市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解生物製程验证市场的竞争格局

生物过程验证市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵生物製程验证市场供应商的绩效评估

FPNV 定位矩阵是评估生物製程验证市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了生物过程验证市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，生物工艺验证市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 精确的安全和品质法规
      • 生物製药需求增加
      • 外包生物製程验证的需求不断成长
    • 抑制因素
      • 生物製程验证成本高
    • 机会
      • 开发下一代生物产品的新检验方法
      • 细胞和基因疗法在医疗保健领域的出现
    • 任务
      • 检验过程的功能问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章按测试类型分類的生物製程验证市场

  • 相容性测试服务
  • 萃取物或可浸出物测试服务
  • 完整性测试服务
  • 微生物检测服务

第七章依製程组成部分分類的生物製程验证市场

  • 反应器
  • 滤芯
  • 冷冻/解冻加工袋
  • 媒体容器和袋子
  • 混合系统
  • 传输系统

第 8 章生物製程验证市场：依最终用户分类

  • 生技公司
  • 合约开发和製造组织
  • 製药公司

第九章美洲生物製程验证市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太生物製程验证市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的生物製程验证市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Almac Group
  • BiOZEEN
  • Eurofins Scientific SE
  • Hangzhou Anow Microfiltration Co., Ltd.
  • Hangzhou Cobetter Filtration Equipment Co., Ltd.
  • Intertek Group PLC
  • Meissner Filtration Products, Inc.
  • Merck KGaA
  • Nelson Laboratories, LLC by Sotera Health company
  • Pall Corporation
  • Porvair PLC
  • Sartorius AG
  • SGS SA
  • Thermo Fisher Scientific, Inc.
  • West Pharmaceutical Services, Inc.
Product Code: MRR-4316E4E891B6

The Bioprocess Validation Market was valued at USD 395.47 million in 2023, expected to reach USD 453.57 million in 2024, and is projected to grow at a CAGR of 14.78%, to USD 1,038.34 million by 2030.

Bioprocess validation encompasses a critical component in the biotechnology and pharmaceutical industries, focusing on ensuring that processes involved in the production of biologics are consistent, effective, and capable of consistently producing products meeting predetermined specifications and quality attributes. The necessity of bioprocess validation arises from the stringent regulatory requirements imposed by agencies like the FDA and EMA, demanding rigorous evidence of process consistency and product safety. Its applications span across various stages of drug development and manufacturing, from culture growth and harvest to purification and formulation, impacting key end-users such as biopharmaceutical companies, contract manufacturing organizations (CMOs), and R&D institutes. Market growth is predominantly influenced by the increasing demand for biologics and biosimilars, investments in biopharmaceutical R&D, and the growing focus on personalized medicine. Additionally, technological advancements in process analytical technologies (PAT) and automation offer significant potential opportunities for enhancing bioprocess efficiencies and ensuring compliance. Companies can capitalize on these opportunities by investing in innovative solutions for real-time monitoring and control of bioprocesses, as well as integrating artificial intelligence and machine learning for predictive analytics and quality management systems. However, the market faces challenges such as high initial costs, complexities in process design, and stringent regulatory frameworks that can stifle innovation and slow down time-to-market. Addressing these challenges requires advancements in cost-effective validation techniques and the development of robust standardized protocols. The best areas for innovation include the exploration of continuous manufacturing methods, incorporation of advanced data analytics for predictive bioprocessing, and improved single-use technologies to enhance flexibility and reduce cross-contamination risks. The market, characterized by its dynamic nature and rapid technological evolution, demands continuous adaptation and forward-thinking strategies to successfully navigate the competitive landscape and drive sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 395.47 million
Estimated Year [2024] USD 453.57 million
Forecast Year [2030] USD 1,038.34 million
CAGR (%) 14.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioprocess Validation Market

The Bioprocess Validation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Precise safety and quality regulations
    • Rising demand for biopharmaceuticals
    • Growing need for outsourcing bioprocess validation
  • Market Restraints
    • High cost of bioprocess validation
  • Market Opportunities
    • Development of new validation methods for next-generation bioproducts
    • Emergence of cell & gene therapy in the healthcare sector
  • Market Challenges
    • Functional issues with validation processes

Porter's Five Forces: A Strategic Tool for Navigating the Bioprocess Validation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioprocess Validation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioprocess Validation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioprocess Validation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioprocess Validation Market

A detailed market share analysis in the Bioprocess Validation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioprocess Validation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioprocess Validation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bioprocess Validation Market

A strategic analysis of the Bioprocess Validation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bioprocess Validation Market, highlighting leading vendors and their innovative profiles. These include Almac Group, BiOZEEN, Eurofins Scientific SE, Hangzhou Anow Microfiltration Co., Ltd., Hangzhou Cobetter Filtration Equipment Co., Ltd., Intertek Group PLC, Meissner Filtration Products, Inc., Merck KGaA, Nelson Laboratories, LLC by Sotera Health company, Pall Corporation, Porvair PLC, Sartorius AG, SGS S.A., Thermo Fisher Scientific, Inc., and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Bioprocess Validation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test Type, market is studied across Compatibility Testing Services, Extractables or Leachables Testing Services, Integrity Testing Services, and Microbiological Testing Services.
  • Based on Process Component, market is studied across Bioreactors, Filter Elements, Freezing & Thawing Process Bags, Media Containers & Bags, Mixing Systems, and Transfer Systems.
  • Based on End User, market is studied across Biotechnology Companies, Contract Development & Manufacturing Organizations, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Precise safety and quality regulations
      • 5.1.1.2. Rising demand for biopharmaceuticals
      • 5.1.1.3. Growing need for outsourcing bioprocess validation
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of bioprocess validation
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of new validation methods for next-generation bioproducts
      • 5.1.3.2. Emergence of cell & gene therapy in the healthcare sector
    • 5.1.4. Challenges
      • 5.1.4.1. Functional issues with validation processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bioprocess Validation Market, by Test Type

  • 6.1. Introduction
  • 6.2. Compatibility Testing Services
  • 6.3. Extractables or Leachables Testing Services
  • 6.4. Integrity Testing Services
  • 6.5. Microbiological Testing Services

7. Bioprocess Validation Market, by Process Component

  • 7.1. Introduction
  • 7.2. Bioreactors
  • 7.3. Filter Elements
  • 7.4. Freezing & Thawing Process Bags
  • 7.5. Media Containers & Bags
  • 7.6. Mixing Systems
  • 7.7. Transfer Systems

8. Bioprocess Validation Market, by End User

  • 8.1. Introduction
  • 8.2. Biotechnology Companies
  • 8.3. Contract Development & Manufacturing Organizations
  • 8.4. Pharmaceutical Companies

9. Americas Bioprocess Validation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bioprocess Validation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bioprocess Validation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Almac Group
  • 2. BiOZEEN
  • 3. Eurofins Scientific SE
  • 4. Hangzhou Anow Microfiltration Co., Ltd.
  • 5. Hangzhou Cobetter Filtration Equipment Co., Ltd.
  • 6. Intertek Group PLC
  • 7. Meissner Filtration Products, Inc.
  • 8. Merck KGaA
  • 9. Nelson Laboratories, LLC by Sotera Health company
  • 10. Pall Corporation
  • 11. Porvair PLC
  • 12. Sartorius AG
  • 13. SGS S.A.
  • 14. Thermo Fisher Scientific, Inc.
  • 15. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOPROCESS VALIDATION MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPROCESS VALIDATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOPROCESS VALIDATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOPROCESS VALIDATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPROCESS VALIDATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPROCESS VALIDATION MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY COMPATIBILITY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY EXTRACTABLES OR LEACHABLES TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY INTEGRITY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MICROBIOLOGICAL TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY FILTER ELEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY FREEZING & THAWING PROCESS BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MEDIA CONTAINERS & BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MIXING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TRANSFER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. BIOPROCESS VALIDATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. BIOPROCESS VALIDATION MARKET, FPNV POSITIONING MATRIX, 2023